Glaxosmithkline | Lånekapital

Loan Capital Endring Dato
AstraZeneca USD 22.97B 2.08B 2023-09
Aurora Cannabis CAD 79.97M 114.74M 2023-03
Corcept Therapeutics USD 0 0 2022-06
Pacira USD 513.8M 2.14M 2023-12
Perrigo USD 4.05B 7.4M 2023-09
Prestige Brands USD 1.2B 63.65M 2023-12
Roche Holding CHF 20.35B 1.05B 2023-06
Supernus Pharmaceuticals USD 0 400.38M 2022-06
Takeda JPY 4.4T 74.11B 2023-09
Teva Pharmaceutical Industries USD 18.5B 203M 2023-09



Glaxosmithkline Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.